Mariner
EVH icon

Mariner’s Evolent Health EVH Stock Holding History

Mariner’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$528K Buy
231,594
+119,486
+107% +$379K ﹤0.01% 2456
2025
Q4 		$448K Buy
112,108
+43,967
+65% +$244K ﹤0.01% 2513
2025
Q3 		$576K Sell
68,141
-13,547
-17% -$131K ﹤0.01% 2316
2025
Q2 		$920K Sell
81,688
-3,702
-4% -$34K ﹤0.01% 1854
2025
Q1 		$809K Buy
+85,390
New +$863K ﹤0.01% 1835

Other funds holding EVH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mariner's EVH Position: Q1 2026 in Review

Mariner increased its Evolent Health (EVH) stake by 107% in Q1 2026, buying an estimated $379K and bringing the position to 231,594 shares worth $528K. The position accounts for ﹤0.01% of the portfolio, ranked #2456.

Mariner first reported a position in EVH in Q1 2025 and has held it in 5 quarters since. The position peaked at $920K in Q2 2025. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Mariner held 231,594 shares of Evolent Health worth $528K as of Q1 2026.
  • Mariner bought 119,486 Evolent Health shares in Q1 2026, an estimated $379K.
  • Evolent Health made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #2456 holding.
  • Mariner first reported a position in Evolent Health in Q1 2025 and has held it in 5 quarters since.
  • Mariner's Evolent Health position peaked at $920K in Q2 2025.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.